InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by PIERCE GLENN, Director. Insider active across 2 companies, notably Global Blood Therapeutics, Inc.. Cumulatively, 7 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €64k. Activity tracked since 13 January 2022. The latest transaction was disclosed on 14 July 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
26,437 sharesCommon StockSEC:0000899243-22-033156:0
9,512 shares@ US$6.70100.0% of flowCommon StockSEC:0001104659-22-080577:0
3,600 sharesCommon StockSEC:0000899243-22-022892:0
26,300 shares0Common StockSEC:0001104659-22-005021:0
26,300 shares0Common StockSEC:0001104659-22-005021
3,037 sharesCommon StockSEC:0000899243-21-024979
3,037 sharesCommon StockSEC:0000899243-21-024979:0
7 of 7 declarations
About PIERCE GLENN
Glenn Pierce is a Board Member and Interim CSO at Global Blood Therapeutics, Inc. and Voyager Therapeutics, Inc. He plays a key role in the governance and strategic direction of these companies, bringing his expertise to the board. His involvement is essential for strategic decision-making.
